atorvastatin
Showing 1 - 25 of 462
Cholesterol Variability, Trained Immunity Trial (Atorvastatin)
Not yet recruiting
- Cholesterol Variability
- Trained Immunity
- Atorvastatin
- (no location specified)
Mar 17, 2023
Overweight Subjects, Obese Subjects Trial in Beijing (metformin, digoxin, IBI362)
Not yet recruiting
- Overweight Subjects
- Obese Subjects
- metformin
- +4 more
-
Beijing, Beijing, ChinaAerospace Center Hospital
Apr 4, 2023
Alagille Syndrome, Atorvastatin, Xanthoma Trial in Shanghai (atorvastatin)
Recruiting
- Alagille Syndrome
- +2 more
- atorvastatin
-
Shanghai, Shanghai, ChinaChildren's Hospital of Fudan University
Aug 3, 2022
Clinical Stage IIA Cutaneous Melanoma AJCC v8 Trial in Portland (drug, procedure, other)
Not yet recruiting
- Clinical Stage IIA Cutaneous Melanoma AJCC v8
- Atorvastatin
- +4 more
-
Portland, OregonOHSU Knight Cancer Institute
Nov 27, 2023
Dyslipidemias, Atherosclerotic Cardiovascular Disease Trial in Seoul (Pitavastatin, Pitavastatin plus Ezetemibe, Atorvastatin)
Not yet recruiting
- Dyslipidemias
- Atherosclerotic Cardiovascular Disease
- Pitavastatin
- +2 more
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Jan 29, 2023
Male Erectile Disorder, Prostate Adenocarcinoma, Erectile Dysfunction, CTCAE Trial in Houston (Atorvastatin, Pentoxifylline,
Completed
- Male Erectile Disorder
- +3 more
- Atorvastatin
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 21, 2022
Breast Cancer, Breast Tumors, Cancer of Breast Trial in New York (Metformin, Atorvastatin, Breast surgery)
Active, not recruiting
- Breast Cancer
- +2 more
- Metformin
- +2 more
-
New York, New YorkColumbia University Medical Center - Herbert Irving Cancer Cente
Aug 16, 2022
Primary Hypercholesterolemia Trial (Ezetimibe, Atorvastatin, Rosuvastatin)
Hearing Loss, Head Neck Cancer Trial run by the National Institute on Deafness and Other Communication Disorders (NIDCD)
Not yet recruiting
- Hearing Loss
- Head and Neck Cancer
- Atorvastatin
- Placebo
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Hypercholesterolemia, Atherosclerosis Trial (Ezetimibe + Atorvastatin, Atorvastatin)
Completed
- Hypercholesterolemia
- Atherosclerosis
- Ezetimibe + Atorvastatin
- Atorvastatin
- (no location specified)
Feb 7, 2022
Abortion Early Trial in Salt Lake City (Atorvastatin, Misoprostol)
Recruiting
- Abortion Early
- Atorvastatin
- Misoprostol
-
Salt Lake City, UtahPlanned Parenthood Association of Utah
Apr 26, 2022
Cerebral Cavernous Malformation Trial in Chicago (Atorvastatin, Placebo)
Active, not recruiting
- Cerebral Cavernous Malformation
- Atorvastatin
- Placebo
-
Chicago, IllinoisUniversity of Chicago
Jul 26, 2022
Type 2 Diabetes Trial in Seoul (Irbesartan/atorvastatin fixed dose combination, Irbesartan SR47436, Atorvastatin)
Completed
- Type 2 Diabetes Mellitus
- Irbesartan/atorvastatin fixed dose combination
- +2 more
-
Seoul, Korea, Republic ofKorea
Apr 5, 2022
Healthy Adults Trial in Anaheim (PF-06882961, Atorvastatin, Midazolam)
Completed
- Healthy Adults
- PF-06882961
- +3 more
-
Anaheim, CaliforniaAnaheim Clinical Trials, LLC
Jul 21, 2022
Independent Living, Disability Free Survival, Elderly Trial in Australia (Atorvastatin, Placebo (for Atorvastatin))
Recruiting
- Independent Living
- +3 more
- Atorvastatin
- Placebo (for Atorvastatin)
-
Hobart, Tasmania, Australia
- +5 more
Nov 28, 2022
Coronary Disease Trial in Assiut (Atorvastatin)
Completed
- Coronary Disease
- Atorvastatin
-
Assiut, EgyptAssiut University
Feb 15, 2022
Hypercholesterolemia Trial (Ezetimibe, atorvastatin)
Intracerebral Hemorrhage Trial in Szczecin (Atorvastatin, Rosuvastatin, No drugs)
Completed
- Intracerebral Hemorrhage
- Atorvastatin
- +2 more
-
Szczecin, West Pomeranian, PolandPomeranian Medical University
Oct 16, 2023
Acute Myocardial Infarction, Glucose Metabolism Disorders Trial in Beijing (Pitavastatin, Atorvastatin)
Recruiting
- Acute Myocardial Infarction
- Glucose Metabolism Disorders
- Pitavastatin
- Atorvastatin
-
Beijing, Beijing, ChinaFuwai Hospital
May 7, 2022
Neurocognitive Impairment, Mild Trial in Sydney (Atorvastatin, Standard Care)
Recruiting
- Neurocognitive Impairment, Mild
- Atorvastatin
- Standard Care
-
Sydney, New South Wales, AustraliaThe George Institute for Global Health
May 2, 2022